샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787223

세계의 신질수술 시장

Neovaginal Surgery
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 185 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신질수술 시장은 2030년까지 15억 달러에 도달

2024년에 12억 달러로 추정되는 세계의 신질수술 시장은 2030년에는 15억 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 3.9%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 성별 적합 수술은 CAGR 3.6%를 기록하며, 분석 기간 종료시에는 8억 3,790만 달러에 달할 것으로 예측됩니다. 질형성 부전 치료 수술 부문의 성장률은 분석 기간 중 CAGR 4.5%로 추정됩니다.

미국 시장은 3억 3,300만 달러로 추정, 중국은 CAGR 7.1%로 성장 예측

미국의 신질수술 시장은 2024년에 3억 3,300만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년의 CAGR을 7.1%로, 2030년까지 3억 990만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.6%와 3.0%로 예측됩니다. 유럽에서는 독일이 CAGR 2.2%로 성장할 것으로 예측됩니다.

세계 신 질 수술 시장 - 주요 동향 및 촉진요인 요약

현대 의학에서 신질 수술이 점점 더 중요해지는 이유는 무엇인가?

질 재건 수술은 재건 수술과 성전환 수술의 고도로 전문화된 분야로, 의학의 발전으로 질 재건이 필요한 사람들의 선택권이 넓어짐에 따라 그 중요성이 점점 더 커지고 있습니다. 이 수술은 트랜스젠더 여성의 성별 확인 수술, 메이어-로크턴스키-쿠스터-하우저(MRKH) 증후군과 같은 선천성 질환, 외상이나 종양 치료 후 재건 필요 등 다양한 의학적, 개인적 이유로 시행되고 있습니다. 수술 기법의 발전으로 음경반전질성형술, 장질성형술, 조직확장술, 자가피부이식을 이용한 질성형술과 같은 비수술적 방법까지 다양한 접근법으로 치료 성적이 눈에 띄게 향상되고 있습니다. 수술 재료와 수술 후 관리의 발전으로 기능성, 심미적 결과, 환자 만족도가 향상되고 있습니다. 트랜스젠더 헤어케어에 대한 수용과 인식이 높아지면서 신질성형술에 대한 수요도 증가하고 있으며, 이는 이 의료 분야의 전문성 증가로 이어지고 있습니다. 의식과 의학적 전문 지식이 계속 발전하고 있는 가운데, 새로운 질 수술은 재건적 개입을 원하는 사람들에게 신체적, 심리적 이점을 제공하는 삶을 변화시키는 솔루션을 제공합니다.

새로운 질 수술 시장이 직면한 과제는?

새로운 질 수술 시장은 그 중요성이 커지고 있음에도 불구하고 접근성, 치료 결과, 규제 당국의 승인에 영향을 미치는 몇 가지 과제에 직면해 있습니다. 가장 큰 장벽 중 하나는 질 성형술 및 기타 재건 수술을 전문으로 하는 고도로 훈련된 외과 의사의 수가 제한적이라는 점입니다. 시술이 복잡하므로 광범위한 외과적 전문 지식이 필요하며, 전문 의료센터가 아니면 이용할 수 없습니다. 또한 이러한 수술과 관련된 고가의 비용은 많은 환자들에게 경제적 어려움을 야기하고 있으며, 특히 젠더 긍정 치료 및 재건 수술이 보험 적용이 되지 않는 지역에서는 이러한 문제가 발생하고 있습니다. 또 다른 문제는 협착, 감염, 기능 제한 등의 수술 후 합병증 위험이며, 이는 장기간의 경과 관찰과 관리가 필요합니다. 또한 수술 후 재활치료에 대한 표준화된 프로토콜이 존재하지 않아 환자 결과에 차이가 발생하고 있습니다. 윤리적, 법적 고려사항 또한 시장 성장을 제한하는 요인 중 하나입니다. 성전환 수술에 대한 규제 당국의 수용도가 국가마다 다르기 때문입니다. 트랜스젠더의 의료 및 재건 수술과 관련된 낙인은 접근성을 더욱 제한하고, 일부 사람들은 필요한 의료 서비스를 받지 않으려는 경향이 있습니다. 이러한 문제를 해결하기 위해서는 의료 기술 혁신뿐만 아니라 정책 개혁, 외과 의사의 수련 기회 증가, 재건 수술과성 정체성 유지 수술에 대한 사회적 수용성 확대가 필요합니다.

기술의 발전은 어떻게 새로운 질 수술을 재구성하고 있는가?

기술의 발전은 새로운 질 수술의 정확성, 안전성, 유효성을 향상시키는 데 매우 중요한 역할을 하고 있습니다. 로봇 보조 수술의 통합은 복잡한 수술의 정확도를 높이고, 회복 시간을 단축하며, 기존 수술에 수반되는 위험을 최소화하고 있습니다. 또한 조직공학과 재생 의학의 발전은 기능적이고 생물학적으로 적합한 새로운 질 구조를 만들기 위한 유망 솔루션을 제공합니다. 줄기세포 치료와 생체공학 질 조직에 대한 연구는 장기적인 수술 결과를 개선할 수 있는 새로운 가능성을 열어주고 있습니다. 또 다른 혁신적인 발전은 수술 전 계획과 환자별 수술 가이드에 3D 프린터를 활용함으로써 해부학적 맞춤화가 가능해져 수술의 정확도가 향상되었습니다는 점입니다. 통증 관리 강화 및 확장 기술 최적화 등 수술 후 관리 전략의 개선으로 환자 경험과 기능적 성공률이 더욱 향상되고 있습니다. 또한 원격의료 및 디지털 건강 플랫폼의 등장으로 질성형 수술 환자의 수술 전 검사, 수술 후 모니터링 및 정신건강 지원에 대한 접근성이 증가하고 있습니다. 이러한 기술 혁신은 수술 능력을 향상시킬 뿐만 아니라, 새로운 질 수술 분야의 접근성과 환자 중심의 치료를 향상시키고 있습니다.

새로운 질 수술 시장의 성장 원동력은 무엇인가?

새로운 질 수술 시장의 성장은 성전환 수술에 대한 수요 증가, 수술 기술의 발전, 의료 정책의 개선 등 여러 가지 요인에 의해 주도되고 있습니다. 트랜스젠더의 의료적 요구가 인식되고 수용되면서 질 성형술 및 기타 성전환 수술에 대한 수요가 급증하고 의료 서비스 프로바이더가 제공하는 수술이 확대되고 있습니다. 또한 MRKH 증후군과 같은 선천성 질환에 대한 인식이 높아지면서 질 재건이 필요한 개인에 대한 의료 개입이 증가하고 있습니다. 여러 국가에서 보험 적용 범위가 확대되고, 정부 지원 의료 서비스도 이러한 수술을 경제적으로 쉽게 이용할 수 있도록 돕고 있습니다. 기술의 발전, 특히 로봇 보조 수술과 생체 공학 조직의 발전은 수술 결과를 더욱 향상시키고 합병증을 감소시켜 더 많은 환자가 이러한 개입을 원하고 있습니다. 전문 수술센터와 다학제 의료팀의 네트워크가 확대됨에 따라 전반적인 치료의 질이 향상되고 수술 옵션에 대한 신뢰가 높아졌습니다. 성 다양성과 재건 수술에 대한 사회적 인식이 계속 진화함에 따라 새로운 질 수술에 대한 수요가 증가하여 이 전문 의료 분야의 추가 혁신과 시장 확대를 촉진할 것으로 예측됩니다.

부문

치료 유형(성별 적합 수술, 질형성 부전 치료 수술, 질폐쇄증 치료 수술)

조사 대상 기업의 예

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan N.V.
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute(PPSI)
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴로 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.18

Global Neovaginal Surgery Market to Reach US$1.5 Billion by 2030

The global market for Neovaginal Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Sex Reassignment Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$837.9 Million by the end of the analysis period. Growth in the Vaginal Agenesis Treatment Surgery segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 7.1% CAGR

The Neovaginal Surgery market in the U.S. is estimated at US$333.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$309.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Neovaginal Surgery Market - Key Trends & Drivers Summarized

Why Is Neovaginal Surgery Gaining Significance in Modern Medicine?

Neovaginal surgery, a highly specialized branch of reconstructive and gender-affirming surgery, is becoming increasingly important as medical advancements expand options for individuals requiring vaginal reconstruction. This surgical procedure is performed for various medical and personal reasons, including gender-affirming procedures for transgender women, congenital conditions such as Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, and reconstructive needs following trauma or oncological treatments. The evolution of surgical techniques has significantly improved outcomes, with approaches ranging from penile inversion vaginoplasty and intestinal vaginoplasty to non-surgical options such as tissue expansion and vaginoplasty using autologous skin grafts. Advancements in surgical materials and postoperative care have enhanced functionality, aesthetic outcomes, and patient satisfaction. The growing acceptance and recognition of transgender healthcare have also contributed to the rising demand for neovaginal procedures, leading to increased specialization in this medical field. As awareness and medical expertise continue to evolve, neovaginal surgery is providing life-changing solutions for individuals seeking reconstructive interventions, offering both physical and psychological benefits.

What Are the Challenges Facing the Neovaginal Surgery Market?

Despite its growing importance, the neovaginal surgery market faces several challenges that impact accessibility, procedural outcomes, and regulatory approvals. One of the most significant barriers is the limited availability of highly trained surgeons specializing in vaginoplasty and other reconstructive techniques. The complexity of the procedure requires extensive surgical expertise, making it accessible only in specialized medical centers. Additionally, the high cost associated with these surgeries poses financial challenges for many patients, particularly in regions where gender-affirming care or reconstructive surgeries are not covered by insurance. Another challenge is the risk of postoperative complications, including stenosis, infections, and functional limitations, which require long-term follow-up and care. Furthermore, there is a persistent lack of standardized protocols for post-surgical rehabilitation, leading to variability in patient outcomes. Ethical and legal considerations also play a role in limiting market growth, as different countries have varying levels of regulatory acceptance regarding gender-affirming surgeries. The stigma associated with transgender healthcare and reconstructive procedures further restricts access and discourages some individuals from seeking necessary medical care. Addressing these challenges requires not only medical innovation but also policy reforms, increased training opportunities for surgeons, and broader societal acceptance of reconstructive and gender-affirming procedures.

How Are Technological Advancements Reshaping Neovaginal Surgery?

Technological advancements are playing a pivotal role in improving the precision, safety, and effectiveness of neovaginal surgery. The integration of robotic-assisted surgery is enhancing the accuracy of complex procedures, reducing recovery times, and minimizing risks associated with traditional surgical techniques. Additionally, advancements in tissue engineering and regenerative medicine are offering promising solutions for creating functional and biologically compatible neovaginal structures. Research into stem cell therapies and bioengineered vaginal tissues has opened new possibilities for improving long-term surgical outcomes. Another transformative development is the use of 3D printing for pre-surgical planning and patient-specific surgical guides, allowing for better anatomical customization and improved surgical accuracy. Improved postoperative care strategies, including enhanced pain management and optimized dilation techniques, are further enhancing patient experience and functional success rates. Moreover, the rise of telemedicine and digital health platforms is increasing access to preoperative consultations, postoperative monitoring, and mental health support for patients undergoing neovaginal procedures. These technological innovations are not only advancing surgical capabilities but also improving accessibility and patient-centered care in the field of neovaginal surgery.

What Is Driving the Growth of the Neovaginal Surgery Market?

The growth in the neovaginal surgery market is driven by several factors, including increasing demand for gender-affirming procedures, advancements in surgical techniques, and improved healthcare policies. The rising visibility and acceptance of transgender healthcare needs have led to a surge in demand for vaginoplasty and other gender-affirming surgeries, prompting healthcare providers to expand their offerings. Additionally, congenital conditions such as MRKH syndrome are becoming more widely recognized, leading to increased medical interventions for individuals requiring vaginal reconstruction. The expansion of insurance coverage and government-backed healthcare initiatives in various countries is also making these procedures more financially accessible. Technological advancements, particularly in robotic-assisted surgery and bioengineered tissues, are further enhancing surgical outcomes and reducing complications, attracting more patients to seek these interventions. The growing network of specialized surgical centers and multidisciplinary healthcare teams is improving the overall quality of care, fostering greater confidence in surgical options. As societal attitudes toward gender diversity and reconstructive surgery continue to evolve, the demand for neovaginal procedures is expected to increase, driving further innovation and market expansion in this specialized field of medicine.

SCOPE OF STUDY:

The report analyzes the Neovaginal Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan N.V.
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute (PPSI)
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neovaginal Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Gender-Affirming Care Policies Across Healthcare Systems Strengthens Business Case for Neovaginal Surgery
    • Growing Awareness and Acceptance of Transgender Healthcare Expands Addressable Market Opportunity
    • Advances in Surgical Techniques and Tissue Engineering Drive Adoption of Neovaginal Surgery Procedures
    • Increasing Insurance Coverage for Gender Reassignment Surgeries Propels Market Growth
    • Expansion of Transgender-Friendly Healthcare Facilities Accelerates Demand for Specialized Surgical Services
    • Surge in Medical Tourism for Gender-Affirming Procedures Throws the Spotlight on High-Quality Surgical Offerings
    • Development of Minimally Invasive Neovaginal Construction Methods Spurs Growth in Patient Preference
    • Emergence of Robotic-Assisted Surgery Enhances Precision and Drives Premium Pricing Potential
    • Strong Advocacy and Support from LGBTQ+ Organizations Strengthens Policy Push and Market Access
    • Integration of Regenerative Medicine Techniques Expands Innovation Frontier and Market Attractiveness
    • Rising Number of Transgender Individuals Seeking Transition Surgeries Generates Sustained Demand
    • Inclusion of Neovaginal Surgery in National Healthcare Guidelines Drives Institutional Adoption
    • Increasing Collaboration Between Medical Institutions and Transgender Health Experts Bolsters Clinical Standards
    • Regulatory Support for Gender-Affirming Care Accelerates Hospital and Clinic Participation
    • Social Media and Influencer-Led Education Campaigns Spur Awareness and Demand Among Younger Demographics
    • Improved Post-Operative Outcomes and Patient Satisfaction Rates Propel Long-Term Market Confidence
    • Training and Certification Programs for Surgeons Drive Growth of Skilled Workforce and Procedure Uptake
    • Expanding Availability of Customizable Surgical Techniques Enhances Patient-Centric Approaches and Market Differentiation
    • Advances in Preoperative Imaging and Simulation Tools Strengthen Case for Personalized Surgical Planning
    • Ethical and Legal Debates Around Access to Gender-Affirming Care Create Regulatory Complexity and Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neovaginal Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Sex Reassignment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Vaginal Agenesis Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaginal Atresia Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • JAPAN
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CHINA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • EUROPE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • FRANCE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • GERMANY
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • INDIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AFRICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제